As the COVID-19 pandemic surged, many repurposed drugs entered the spotlight, with ivermectin—an antiparasitic medication—becoming a controversial candidate. From social media advocacy to early observational studies suggesting promise, public interest ballooned. However, a recent high-quality systematic review and meta-analysis have started painting a much clearer...
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Romaian
Portuguese (Brazil)
Greek